| Abstract: |
Chemotherapy-induced oral mucositis (CIOM) significantly impacts the quality of life in head and neck cancer patients, causing pain, difficulty in eating, and treatment interruptions. This comparative study evaluated the effectiveness of Yashtimadhu (Glycyrrhiza glabra) versus Triphala in managing CIOM and improving quality of life among 120 patients undergoing chemotherapy at a tertiary care hospital in India. Participants were randomly assigned to Yashtimadhu group (n=40), Triphala group (n=40), or control group (n=40) receiving standard care. The study employed WHO oral mucositis grading scale and EORTC QLQ-C30 quality of life questionnaire as assessment tools. Results demonstrated that Yashtimadhu significantly reduced mucositis severity (p |
